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Abstract
Background A randomized controlled trial showed that
patients with grade III or IV internal hemorrhoids had
similar symptomatic relief of symptoms up to 3 months
following dearterialization with mucopexy or hemor-
rhoidectomy albeit with less postoperative pain after the
former. This study aimed to compare hemorrhoidal recur-
rence and chronic complications at 3-year follow-up.
Methods This study was carried out on 40 patients with
grade III or IV internal hemorrhoids previously enrolled to
a randomized trial comparing dearterialization to hemor-
rhoidectomy. Recurrence was defined as internal hemor-
rhoids diagnosed on proctoscopy. Chronic complications
were nonresolving adverse events related to surgery. Out-
come measures included patient-reported outcomes and
quality of life measured by brief pain inventory (BPI), SF-
12, and fecal incontinence surveys.
Results At median follow-up of 36 (27–43) months, 13
patients (32.5 %) were lost to follow-up. Patient-reported
outcomes suggested no difference between dearterialization
and hemorrhoidectomy in persistent symptoms, occurring in
1 (8.3 %) vs. 2 (13.3 %) patients (p = 0.681) and in symp-
tom recurrence, occurring in 6 (50 %) vs. 4 (26.7 %) patients
(p = 0.212). On proctoscopy, recurrence was seen in 2
(13.3 %) vs. 1 (6.7 %) patients (p = 0.411), all with index
grade IV disease. One patient in each arm required reoper-
ation (p = 0.869). Chronic complications were not seen in
the dearterialization arm while they occurred in 2 (13.3 %)
hemorrhoidectomy patients (p = 0.189) and included
unhealed wound (n = 1), anal fissure (n = 1) and fecal
incontinence (n = 1). There was a trend toward more patient
reported than actual recurrence on proctoscopy (10 vs. 3,
p = 0.259). There was no difference in BPI, SF-12, and fecal
incontinence quality of life scores.
Conclusions Recurrence rates did not differ significantly
at 3-year follow-up and occurred in patients with index
grade IV hemorrhoids. Chronic complications occurred
only after hemorrhoidectomy.
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Introduction
Hemorrhoidal artery dearterialization was first described as
a treatment for internal hemorrhoids in 1995 by Morinaga
[1] and has been popularized over the last decade with the
development of specialized anoscopes, which facilitate this
procedure. However, there is still controversy and skepti-
cism surrounding this procedure as an alternative to hem-
orrhoidectomy or stapled hemorrhoidopexy. While there is
a sufficient short-term data in the surgical literature, long-
term data and randomized data are lacking. While three
quadrant excisional hemorrhoidectomy is considered the
gold standard procedure for advanced hemorrhoidal dis-
ease, it is not a perfect operation. There is a significant pain
and morbidity in the short term, and recurrence and chronic
complications are reported in the long term. A British study
with 17-year follow-up reported 26 % recurrence of hem-
orrhoids after excisional hemorrhoidectomy [2], and
another study with median of 7-year follow-up reported
that 40 % of patients complained of recurrent symptoms
and 4 % developed anal strictures [3]. In 2013, we pub-
lished the short-term results of a randomized controlled
P. Denoya  J. Tam  R. Bergamaschi (&)
Division of Colon and Rectal Surgery, Health Science Center,




Tech Coloproctol (2014) 18:1081–1085
DOI 10.1007/s10151-014-1219-8
study treating grade III and IV internal hemorrhoids with
either hemorrhoidal dearterialization with mucopexy or
Ferguson hemorrhoidectomy [4]. The study found less
postoperative pain in the dearterialization patients and
similar resolution of preoperative symptoms with up to
3-month follow-up. The aim of this study is to report and
characterize the long-term results of these two techniques.
Methods
Study design
This was a follow-up study performed by telephone survey of
patients who underwent either hemorrhoidal dearterialization
with mucopexy or excisional hemorrhoidectomy as part of a
randomized double-blinded trial [4]. All the patients included
in the study had grade III or IV internal hemorrhoids in a
minimum of three quadrants. Grade III internal hemorrhoids
prolapse but are reducible and grade IV internal hemorrhoids
prolapse and are not reducible by the patient or do not remain
reduced [5]. Diagnosis was established by examination and
anoscopy or proctoscopy by a colorectal surgeon. As patients
often present with anorectal symptoms, which may be due to
causes other than internal hemorrhoids, only patients who
were symptomatic and were found to have grade III or IV
internal hemorrhoids on examination were included in the
study. This assured a reproducible patient population. Patients
were excluded if they had undergone surgery for hemorrhoids
previously. The procedures were performed under general
anesthesia or intravenous sedation with local anesthetic
infiltration, in the ambulatory surgery setting. Hemorrhoidal
dearterialization with mucopexy was performed using the
THD kit (THD Italy, Corregio, Italy). The surgical technique
involves identifying six hemorrhoidal arteries by Doppler
guidance and suture ligating each one separately with a 2–0
absorbable suture. The same suture is then used to perform the
mucopexy up to 1 cm proximal to dentate line. This technique
was described by Ratto et al. [6]. The hemorrhoidectomy was
performed as described by Ferguson and Heaton [7]. Each
hemorrhoid was excised by an elliptical incision under
exposure by an anal retractor. The incision was extended
cephalad. The hemorrhoidal pedicle was suture ligated, and
the incision was closed primarily. Patients were all discharged
to home on the same day, with a prescription for hydrocodone
or oxycodone and instructions to use stool softeners, water
baths, and laxatives. They were seen 2 weeks after surgery
and followed routinely up to 3 months. Following that period,
they were seen on an as needed basis.
Institutional review board approval was obtained for this
study. Patients were contacted by telephone and asked to
participate in the survey. The telephone surveys were
conducted by a blinded research assistant, who also
reviewed the chart for additional data. Patients who
reported continued or recurrent anal symptoms were asked
to return to the office for examination by the surgeon.
Study endpoints
The primary endpoint for this study was rate of recurrence
of internal hemorrhoids. Recurrence was defined as internal
hemorrhoids seen by the colorectal surgeon on anoscopic
or proctoscopic examination in patients who were symp-
tomatic. Additional endpoints examined included chronic
complications, need for reoperations, and patient-reported
outcomes such as anal pain, anal bleeding, other anal
symptoms, current level of pain, level of fecal continence,
and overall quality of life. Chronic complications included
anal stenosis, unhealed wounds, and anal fissures persistent
since surgery, and fecal incontinence developing immedi-
ately after surgery. Current level of pain was measured
using the brief pain inventory (BPI), which is a validated
pain assessment tool based on the Wisconsin Brief Pain
questionnaire [8–10]. Fecal continence was measured using
the Fecal Incontinence Quality of Life tool [11]. Overall
quality of life was measured using the SF-12 tool [12].
Statistical methods
Patient data were entered into a Microsoft Excel
spreadsheet. SPSS software was used to analyze the data.
Pearson’s chi-squared test was used for categorical data,
and Student’s t test was used for continuous data. Signifi-
cance was predetermined at a = 0.05.
Results
Of the original 40 patients, 12 were lost to follow-up and 1
dearterialization patient refused to participate, resulting in
a 68 % retention rate. A total of 12 dearterialization
patients and 15 hemorrhoidectomy patients were included
in the study. The median follow-up was 35 months (range
27–43). The two arms of patients had similar demographics
except for gender distribution (42 vs. 94 % male,







Gender 5 (41.7 %) 14 (93.9 %) 0.003
Age at index
surgery
53.8 ± 8.8 53.1 ± 9.0 0.854
BMI 28.5 ± 6.9 29.3 ± 5.6 0.732
ASA 2.1 ± 0.3 1.9 ± 0.5 0.333
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All of the patients who reported recurrent or persis-
tent anorectal symptoms on the telephone survey
returned to the office for examination. Recurrence of
internal hemorrhoids was found on physician examina-
tion in two dearterialization patients and one hemor-
rhoidectomy patient (16.7 vs. 6.7 %, p = 0.411). One
dearterialization patient was found to have a single
grade III internal hemorrhoid, which was treated with
repeat dearterialization, and the other patient had
recurrent grade IV hemorrhoids and opted for nonop-
erative management with stool softener and fiber sup-
plementation. The patient who recurred after
hemorrhoidectomy was found to have grade IV hemor-
rhoids and was treated with repeat hemorrhoidectomy.
This patient had three very large prolapsing hemor-
rhoids at the index operation. On examination at the
time of recurrence, he again had three large prolapsing
hemorrhoids and significant bleeding requiring blood
transfusion. These results are summarized in Table 2.
All three patients who had a recurrence had grade IV
internal hemorrhoids prior to the index surgery. Addi-
tional findings reported on physician examination were
external residual skin tags in five dearterialization
patients and one hemorrhoidectomy patient. Chronic
complications were reported in no dearterialization
patients and two hemorrhoidectomy patients (Table 3).
These included an unhealed wound in one patient and a
fissure and fecal incontinence in another.
In the telephone survey results, one dearterialization
patient and two hemorrhoidectomy patients reported that
the symptoms for which they had surgery never resolved
(p = 0.681). Six dearterialization patients and four hem-
orrhoidectomy patients reported recurrent symptoms,
including anal pain, bleeding, and itching (p = 0.212).
(Table 4) These symptoms were treated with stool soften-
ers, fiber supplements, warm water baths, and ointments, or
suppositories. Interestingly, there was a difference between
patient-reported recurrent symptoms (10) and actual con-
firmation of recurrent internal hemorrhoids (3) by a phy-
sician (p = 0.259), though it was not statistically
significant.
The BPI was used to assess current pain in the patients.
Results were similar in both pain severity (p = 0.481) and
interference in lifestyle due to pain (p = 0.259) between
the two arms. Quality of life was assessed both in terms of
overall quality (SF-12) and in terms of incontinence (FI-
QOL). In both scales, the quality of life results were similar
in both arms of the study. Results are summarized in
Table 5.
Table 2 Physician-reported recurrence of internal hemorrhoids
Dearterialization
n = 12 (%)
Hemorrhoidectomy





2 (16.7) 1 (6.7) 0.411
Treated by
intervention
1 (8.3) 1 (6.7) 0.869
THD 1 (8.3) 0 (0.0) 0.255
Ferguson 0 (0.0) 1 (6.7) 0.362
Nonoperative
management
1 (8.3) 0 (0.0) 0.255
Table 3 Physician-reported chronic complications
Dearterialization
n = 12 (%)
Hemorrhoidectomy
n = 15 (%)
P
Any complication 0 (0.0) 2 (13.3) 0.189
Anal stenosis 0 (0.0) 0 (0.0) -
Unhealed wound 0 (0.0) 1 (6.7)* 0.362
Fissure 0 (0.0) 1 (6.7) 0.362
Fecal incontinence 0 (0.0) 1 (6.7)* 0.362
* Same patient
Table 4 Patient-reported outcomes
Dearterialization
n = 12 (%)
Hemorrhoidectomy








6 (50.0) 4 (26.7) 0.212
Anal pain 1 (8.3) 1 (6.7) 0.869
Anal bleeding 2 (16.7) 2 (13.3) 0.809
Anal itching 1 (8.3) 0 (0.0) 0.255








0.25 ± 0.62 0.60 ± 1.60 0.481
BPI pain
interference
0.08 ± 0.29 0.40 ± 0.91 0.259
FIQOL
Lifestyle 1.18 ± 0.60 1.13 ± 0.52 0.827
Coping 1.27 ± 0.91 1.13 ± 0.52 0.623
Depression 1.18 ± 0.60 1.20 ± 0.56 0.938
Embarrassment 1.27 ± 0.91 1.13 ± 0.52 0.623
SF-12
PCS 56.09 ± 2.59 55.47 ± 3.31 0.609
MCS 55.09 ± 6.91 55.80 ± 6.86 0.797
Tech Coloproctol (2014) 18:1081–1085 1083
123
Discussion
The gold standard surgical treatment for hemorrhoids is
excisional hemorrhoidectomy. While this method seems to
have the best long-term result in terms of recurrence of
disease, it has several drawbacks. These include significant
postoperative pain, bleeding, constipation, urinary reten-
tion, and long-term complications such as anal stenosis,
nonhealing wounds, residual skin tags, and anal inconti-
nence. Surgeons have developed several less invasive
procedures in the search for a balance between acceptable
relief of symptoms and less postoperative pain and other
complications. As with all new procedures, long-term
results take years to study, and the technology often
becomes accepted into practice without knowing how the
procedure will hold up to the test of time.
Hemorrhoidal artery dearterialization was described two
decades ago, but did not become popular until more
recently; therefore, long-term results are not widely avail-
able. Additionally, many different terms are used to
describe essentially the same procedure in the literature. In
order to identify studies reporting on this procedure, one
must use multiple terms, including combinations of
‘‘transanal hemorrhoidal dearterialization (THD),’’
‘‘Doppler-guided hemorrhoidal artery ligation (DGHAL),’’
‘‘mucopexy,’’ ‘‘anopexy,’’ ‘‘suture mucosal pexy,’’ and
‘‘rectoanal repair.’’ Randomized trials or even comparative
studies such as case–control retrospective series are rarely
available.
Zampieri et al. [13] reported in 2012 on a randomized
trial studying transanal hemorrhoidal dearterialization with
proctopexy and ligasure hemorrhoidectomy. The study
included 114 patients, and follow-up was 1 year. Follow-
up was conducted by telephone interview. Patients inclu-
ded had at least grade III internal hemorrhoids. The pri-
mary-reported outcome was resolution of pain. At
6 months, THD patients had statistically significantly less
pain than hemorrhoidectomy patients, but at 1 year, pain
was similar between the two groups. Recurrence of internal
hemorrhoids was not reported.
Another researcher randomized 40 patients to either
THD with anopexy or hemorrhoidectomy [14]. All patients
had grade II or III internal hemorrhoids. At 1-year follow-
up, two patients who underwent THD had remaining grade
III hemorrhoids and seven patients had grade II hemor-
rhoids, and one patient who underwent hemorrhoidectomy
had remaining grade III hemorrhoids and three patients had
Grade II hemorrhoids. This difference in residual hemor-
rhoids was not statistically significant between the groups.
Infantino et al. [15] randomized 167 patients to receive
either stapled hemorrhoidopexy (PPH) or THD. All
patients had grade III internal hemorrhoids. The authors
report similar short-term complications, with long-term
complications occurring only in the PPH group. They
report persistence or recurrence of internal hemorrhoids in
14 % of THD patients and 7 % of PPH patients, which was
not a statistically significant difference. The mean follow-
up was 17 months.
Avital et al. [16] reported 5-year follow-up on 100
patients who underwent DGHAL without mucopexy by a
single surgeon for grade II and III internal hemorrhoids.
Ninety-six patients answered the survey at 1 year and 92 at
5 years. In total, 89 % were asymptomatic at 1 year and
73 % at 5 years. They found that most recurrences occur-
red during the first year after surgery, and there was a trend
toward more recurrence in patients with grade III internal
hemorrhoids.
Faucheron et al. [17] reported long-term results of 100
patients with grade IV internal hemorrhoids who under-
went DGHAL with rectoanal repair. The patients were
prospectively followed for a mean of 34 months. In total,
9 % had a recurrence of hemorrhoidal prolapse at
11 months. Treatment for recurrence included repeat
DGHAL in three patients, hemorrhoidectomy in three
patients, and nonoperative management in the other three
patients.
De Nardi et al. [18] recently reported a randomized trial
of 50 patients with grade III internal hemorrhoids who
underwent either THD with mucopexy or hemorrhoidec-
tomy. The study period was up to 24 months. The authors
noted less pain in the THD arm in the first postoperative
week, but no difference in pain thereafter. Regarding
recurrent symptoms, both techniques were equivalent after
2 years of follow-up.
In this study, we report long-term results of a random-
ized trial of patients with grade III or IV internal hemor-
rhoids who underwent either transanal hemorrhoidal
dearterialization (THD) with mucopexy or three quadrant
excisional hemorrhoidectomy and were followed for a
median of 35 months. The recurrence of internal hemor-
rhoids did not differ significantly between the two groups.
Additionally, all the patients who recurred in both arms had
grade IV internal hemorrhoids at the time of the index
operation. Long-term complications, including unhealed
wounds, fissures, and incontinence, were only found in
patients who underwent hemorrhoidectomy, though this
difference was not statistically significant. The patients
themselves reported similar numbers of symptoms and
recurrence in both arms, and quality of life and pain scores
were similar in both arms as well.
This study has several weaknesses. We lost 13 patients
from follow-up, which leads to lower numbers and selec-
tion bias. This is an unfortunate consequence of our patient
population, which tends to change address or phone num-
bers frequently when compared to some European popu-
lations. However, this reflects the real-life scenario of any
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long-term follow-up study in the USA. The demographics
of the patients were similar in both arms except for gender
distribution. Additionally, there were no changes in surgi-
cal technique during the study period, and the two surgeons
involved performed both operations during the entire per-
iod of time. As with any long-term study, the patients
themselves choose whether to participate in the survey or
not, so this may lead to some selection or reporting bias.
This may lead to over or under reporting of recurrences or
complications depending on which patients choose to
answer the questions. The total number of patients was
small, so it is possible that in a larger patient population,
the difference in recurrence of hemorrhoids would have
been statistically significant. However, the number of
patients included is similar to other two-arm studies.
However, the study has significant strengths. We com-
pared two surgical treatments for hemorrhoids. We had
strict definitions of the severity of disease being treated, as
well as definitions of complications. We used validated
means of collecting patient-reported outcomes, such as the
BPI, SF-12 scale, and FIQOL questionnaire. The length of
the follow-up period is almost 3 years, which makes this
one of the longer studies reporting on hemorrhoidal dear-
terialization in the literature. As reported in several other
studies, most recurrences occur within the first postopera-
tive year, so it is safe to assume that 3-year follow-up is an
adequate measure of success for this technique.
In conclusion, this study suggests that hemorrhoidal
dearterialization with suture mucopexy is as good as
hemorrhoidectomy in the longer term, both in terms of
actual recurrence of internal hemorrhoids and in terms of
patient satisfaction. It may be more appropriate for grade
III internal hemorrhoids, but may successfully be used in
grade IV disease as well. In addition, dearterialization is a
safe procedure, which not only provides less postoperative
pain in the short term, but also enjoys a low occurrence of
chronic complications.
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